Search
for

    Sort by

    Research 601–630 of 1000+

    1. Diagnostic Criteria for Polycystic Ovarian Syndrome Endocrine journal · 2006 · 45 citations
    2. Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation AJP Endocrinology and Metabolism · 2011 · 43 citations
    3. Acanthosis nigricans, insulin resistance and cutaneous virilism British Journal of Dermatology · 1988 · 43 citations
    4. Evidence-based approach to cutaneous hyperandrogenism in women Journal of The American Academy of Dermatology · 2015 · 42 citations
    5. Mood disorders and quality of life in polycystic ovary syndrome Gynecological Endocrinology · 2015 · 42 citations
    6. Non-classic congenital adrenal hyperplasia Steroids · 2013 · 42 citations
    7. Polycystic Ovary Syndrome and Its Differential Diagnosis Obstetrical & Gynecological Survey · 2006 · 42 citations
    8. Hair removal in hirsute women with normal testosterone levels: a randomized controlled trial of long-pulsed diode laser vs. intense pulsed light 2010 · 41 citations
    9. Direct-Acting Vasodilators ˜The œjournal of clinical hypertension · 2011 · 40 citations
    10. Polycystic ovary syndrome (PCOS) Annales D Endocrinologie · 2010 · 40 citations
    11. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare Reproductive Biology and Endocrinology · 2012 · 39 citations
    12. Tissue insulin sensitivity and body weight in polycystic ovary syndrome Clinical endocrinology · 2001 · 39 citations
    13. Antiandrogens: Clinical applications The Journal of Steroid Biochemistry and Molecular Biology · 1990 · 39 citations
    14. An Update on Plant Derived Anti-Androgens international journal of endocrinology and metabolism · 2012 · 38 citations
    15. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction · 2004 · 38 citations
    16. ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE Dermatologic Clinics · 1996 · 38 citations
    17. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome Gynecological Endocrinology · 2008 · 37 citations
    18. Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran Hormone Research in Paediatrics · 2004 · 37 citations
    19. Local and Systemic Reduction by Topical Finasteride or Flutamide of Hamster Flank Organ Size and Enzyme Activity Journal of Investigative Dermatology · 1995 · 37 citations
    20. Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin The Journal of Clinical Endocrinology & Metabolism · 2011 · 36 citations
    21. Pregnancy and the Skin Dermatologic Clinics · 1990 · 36 citations
    22. Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome Journal of Affective Disorders · 2015 · 35 citations
    23. Physiological Skin Changes During Pregnancy Clinical Obstetrics and Gynecology · 2014 · 35 citations
    24. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clinical Endocrinology · 2011 · 35 citations
    25. 7 Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women Clinics in endocrinology and metabolism · 1986 · 35 citations
    26. Androgens in women Journal of The American Academy of Dermatology · 2018 · 34 citations
    27. Cutaneous manifestations of anabolic-androgenic steroid use in athletes International Journal of Dermatology · 2009 · 34 citations
    28. Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin 1993 · 34 citations
    29. What every physician should know about polycystic ovary syndrome Dermatologic therapy · 2008 · 33 citations
    30. The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen Acta obstetricia et gynecologica Scandinavica · 1979 · 33 citations